Fighting prostate cancer with radioactive seeds
In November 1997, a team of surgeons headed by Anthoy D’Amico, an associate professor of radiation oncology at Harvard Medical School, first used a technique that treats early stages of prostate cancer...
View ArticleStudy predicts risk of prostate cancer death
Researchers followed 381 people to “identify predictors of time to prostate specific death following external radiation therapy.” “The results of this study give us a better understanding of what form...
View ArticleMinimally invasive prostate cancer treatment works as well as traditional...
Prostate cancer is the second most common cancer in men and the cause of approximately 29,000 deaths a year. Currently, the most common treatments for prostate cancer include radical prostatectomy (RP)...
View ArticlePopular hair-loss drug impedes prostate cancer detection in middle-aged men
Researchers at Brigham and Women’s Hospital (BWH) have found that the prostate specific antigen (PSA) cancer screening test is falsely lowered by a factor of two in middle-aged men who have taken...
View ArticleFighting prostate cancer with radioactive seeds
In November 1997, a team of surgeons headed by Anthoy D’Amico, an associate professor of radiation oncology at Harvard Medical School, first used a technique that treats early stages of prostate...
View ArticleStudy predicts risk of prostate cancer death
Researchers followed 381 people to “identify predictors of time to prostate specific death following external radiation therapy.” “The results of this study give us a better understanding of what form...
View ArticleMinimally invasive prostate cancer treatment works as well as traditional...
Prostate cancer is the second most common cancer in men and the cause of approximately 29,000 deaths a year. Currently, the most common treatments for prostate cancer include radical prostatectomy...
View ArticlePopular hair-loss drug impedes prostate cancer detection in middle-aged men
Researchers at Brigham and Women’s Hospital (BWH) have found that the prostate specific antigen (PSA) cancer screening test is falsely lowered by a factor of two in middle-aged men who have taken...
View Article
